1. Pfizer

    0 Comments Leave a Comment

    1-15 of 41 1 2 3 »

    1. Mentioned In 41 Articles

    2. Sen. Elizabeth Warren Calls on ex-FDA Chief Gottlieb to Resign from Pfizer’s Board, says it ‘smacks of corruption’

      Explore CNBC.com BoardNews
      Sen. Elizabeth Warren Calls on ex-FDA Chief Gottlieb to Resign from Pfizer’s Board, says it ‘smacks of corruption’
      Sen. Elizabeth Warren on Tuesday called on the former head of the Food and Drug Administration, Scott Gottlieb, to resign from Pfizers board of directors, saying the appointment months after leaving the agency smacks of corruption. This kind of revolving door influence-peddling smacks of...
      Read Full Article
      Mentions: Sen. Elizabeth Warren Pfizer Scott Gottlieb
    17. 1-15 of 41 1 2 3 »
  1. Search:

  2. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content

  3. Related Topics

    1. Yahoo! Names Thompson CEO
      138 articles also mentioned Board of Directors
    2. Shantanu Narayen Elected To Pfizer's Board Of Directors
      83 articles also mentioned MDC Partners
    3. Chrysler Adds Two to Board
      37 articles also mentioned AT&T
    4. Molson Coors Adds Two to Board
      34 articles also mentioned Europe
    5. Thompson Joins Microsoft Board
      32 articles also mentioned Johnson & Johnson

  4. Quotes about Pfizer

    1. We are pleased to welcome Shantanu Narayen to Pfizer's Board of Directors. He brings both leadership experience and a strong technology background to Pfizer's Board and will be an excellent asset to the company.
      Ian Read in Shantanu Narayen Elected To Pfizer's Board Of Directors
    2. We are pleased to have Jim Smith join Pfizer's Board of Directors. He brings leadership and operational and international business experience to Pfizer's Board, and will be an excellent asset to the company.
      Ian Read in James C. Smith Elected to Pfizer’s Board of Directors
    3. Amy is a recognized leader in the development and growth of global pharmaceutical businesses, and she will bring this expertise to our Board as we continue to build Alnylam as a leading biotechnology company. As the former General Counsel at Pfizer, Amy also brings deep legal expertise to our Board.
      In Alnylam Elects Amy Schulman to its Board of Directors